To explore patient and healthcare professional perspectives on post-lower limb reconstruction support. A qualitative study One-to-one semi-structured interviews undertaken via video conferencing software or over the telephone. Thirty-two patients (who had undergone reconstructive surgery due to trauma, malunion, non-union, infection or congenital issues treated by internal or external fixation) and 22 orthopaedic healthcare professionals (surgeons, nurses and physiotherapists) were interviewed between November 2020 and June 2021. Thematic analysis was undertaken on data surrounding clinical support. Four themes were generated: being involved and feeling informed, physiotherapy as a motivator for recovery, the importance of timely access to physiotherapy, and mental health support. Patients valued being involved in decisions about their care and feeling informed. Supportive nurses played a key role, with patients appreciating clear communication and empathy. Trust in the clinical team eased anxiety, whilst a lack of information caused stress and dissatisfaction. Post-surgery, information on recovery, access to physiotherapy, and hospital contacts were crucial. Physiotherapy was vital for regaining mobility, providing motivation, and promoting confidence. Access to mental health support was limited, though patients appreciated emotional support from physiotherapists and hospital staff. By providing comprehensive support, healthcare professionals can optimise patient satisfaction with care, enhance psychological well-being, and facilitate the successful rehabilitation and reintegration of patients back into their daily lives.

Download full-text PDF

Source
http://dx.doi.org/10.1177/02692155251317500DOI Listing

Publication Analysis

Top Keywords

clinical support
8
limb reconstruction
8
healthcare professionals
8
feeling informed
8
access physiotherapy
8
mental health
8
health support
8
support
7
patients
5
patients' staffs'
4

Similar Publications

Cancer therapy-related cardiac dysfunction (CTRCD) is a major concern for patients undergoing cardiotoxic cancer treatments. Sodium-glucose co-transporter-2 (SGLT2) inhibitors have shown cardioprotective effects in both diabetic and non-diabetic populations. However, their impact on CTRCD risk remains uncertain.

View Article and Find Full Text PDF

Objective: To better understand clinicians' rationale for ordering testing for infection (CDI) for patients receiving laxatives and the impact of the implementation of a clinical decision support (CDS) intervention.

Design: A mixed-methods, case series was performed from March 2, 2017 to December 31, 2018.

Setting: Yale New Haven Hospital, a 1,541 bed tertiary academic medical center.

View Article and Find Full Text PDF

Aims: Osteoarthritis (OA) is a widespread chronic degenerative joint disease with an increasing global impact. The pathogenesis of OA involves complex interactions between genetic and environmental factors. Despite this, the specific genetic mechanisms underlying OA remain only partially understood, hindering the development of targeted therapeutic strategies.

View Article and Find Full Text PDF

Objective: To enhance our understanding of the processes of change and the interaction of symptoms, we applied a relatively novel method known as Dynamic Time Warp to data from low-threshold internet-based interventions directed at decreasing eating disorder (ED) symptoms and increasing help-seeking.

Method: Utilizing data from the Featback study, we examined how various factors such as ED psychopathology, binge eating, vomiting, laxative use, BMI, anxiety, depression, self-efficacy, social support, well-being, and health-related quality of life interplayed over a period of 14 months among 355 individuals at six different time points. Moreover, we explored which symptoms exerted a significant temporal relationship on others (with high out-strength) and which were most affected by other symptoms (with high in-strength).

View Article and Find Full Text PDF

The rapidly growing interest in the literature about the anticancer activity of 3,5-disubstituted pyrazolines and their promising therapeutic potentials/pharmacological properties, supported by the number of pyrazoline derivatives currently in clinical use or clinical trials, encouraged us to review the antiproliferative effects and biochemical investigations of probable mechanisms of action. Nevertheless, many reported pyrazoline-bearing compounds have anticancer activity without an explored mode of action, which opens new research avenues to examine their biochemical profiles further. Therefore, 3,5-disubstituted pyrazoline is a promising core that can be used to design new derivatives with anticancer activity based on the structure-activity relationship summarized in this review to obtain higher potency and selectivity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!